Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 30, 2017

DrugPatentWatch Database Preview

Amphetamine - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for amphetamine and what is the scope of amphetamine patent protection?

Amphetamine
is the generic ingredient in twenty-three branded drugs marketed by Neos Theraps, Tris Pharma Inc, Teva, Actavis Elizabeth, Shire, Mylan Pharms Inc, Teva Womens, Barr, Aurolife Pharma Llc, Barr Labs Inc, Sandoz, Mallinckrodt Inc, Corepharma, Impax Labs, Teva Pharms, Sun Pharm Inds, Ucb Inc, Lannett, and Arbor Pharms Llc, and is included in twenty-three NDAs. There are fourteen patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Amphetamine has twenty-one patent family members in fourteen countries.

There are fifty-three drug master file entries for amphetamine. Two suppliers are listed for this compound.

Summary for Generic Name: amphetamine

Tradenames:23
Patents:14
Applicants:19
NDAs:23
Drug Master File Entries: see list53
Suppliers / Packagers: see list2
Bulk Api Vendors: see list25
Clinical Trials: see list59
Patent Applications: see list20,282
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:amphetamine at DailyMed

Pharmacology for Ingredient: amphetamine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Shire
ADDERALL XR 15
amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate
CAPSULE, EXTENDED RELEASE;ORAL021303-006May 22, 2002ABRXYesNoRE42096*PED► Subscribe ► Subscribe
Barr Labs Inc
DEXTROAMP SACCHARATE,AMP ASPARTATE,DEXTROAMP SULFATE AND AMP SULFATE
amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate
CAPSULE, EXTENDED RELEASE;ORAL076536-004Feb 12, 2013ABRXNoNo► Subscribe► Subscribe
Teva
DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE
amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate
CAPSULE, EXTENDED RELEASE;ORAL077488-002Apr 29, 2013ABRXNoNo► Subscribe► Subscribe
Shire
ADDERALL XR 25
amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate
CAPSULE, EXTENDED RELEASE;ORAL021303-004May 22, 2002ABRXYesNo6,605,300*PED► SubscribeY► Subscribe
Teva Pharms
DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE
amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate
TABLET;ORAL040472-004Sep 30, 2003DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Find generic sources and suppliers
  • Formulary management

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot